Clinical implications of PRAME gene expression in childhood acute myeloid leukemia
about
sameAs
Knock-down of PRAME increases retinoic acid signaling and cytotoxic drug sensitivity of Hodgkin lymphoma cellsLeukemia associated antigens: their dual role as biomarkers and immunotherapeutic targets for acute myeloid leukemiaT-cell-based therapies for malignancy and infection in childhood.Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine.Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.Immortalization of mouse germ line stem cells.The tumour antigen PRAME is a subunit of a Cul2 ubiquitin ligase and associates with active NFY promotersRole of Src family kinases and N-Myc in spermatogonial stem cell proliferation.Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.Predicting biomarkers for ovarian cancer using gene-expression microarrays.PRAME expression in hairy cell leukemia.PRAME Gene Expression in Acute Leukemia and Its Clinical SignificancePRAME expression and clinical outcome of breast cancerEx vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia.Vaccines as consolidation therapy for myeloid leukemia.Retinoids: novel immunomodulators and tumour-suppressive agents?Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2 in vitro and in vivo.Identification of Preferentially Expressed Antigen of Melanoma as a Potential Tumor Suppressor in Lung Adenocarcinoma.Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens.Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes.Array CGH analysis reveals deletion of chromosome 22q11 in CLL with normal karyotype and no fish alterations.PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes.PRAME gene expression profile in medulloblastoma.
P2860
Q28486108-B200B8FD-45DD-49BA-9C74-48DC3D0020C1Q33491557-C0D4EC4B-1984-4C1F-A833-5F4B5F4160ADQ33750862-5F7B9502-F821-4F87-B559-232297C7F2FBQ34935239-BC5F8A23-7608-4190-8007-40A4482C3EBAQ35134983-4CB80647-FD99-4273-A9E5-6761BF232C38Q35151330-74F3CF52-AE58-437F-AFB3-7CB6B6FFB39BQ35214905-DB35DEA4-E604-4147-8749-C3AE8387CBD7Q36143495-78E5ED3F-101C-49C7-9B99-034A8D974806Q36153422-C8A5A9CE-E24A-4AED-91C0-E93DAACECC59Q36694599-629FC745-081C-4A2B-AE75-E75C965C316BQ36748859-8365854B-CE6D-48C4-9810-846560EF1A1AQ36814310-FF947D40-E537-461F-ABC4-857172FD87EDQ36858038-4741EA68-DB13-47B9-BD70-08FCE46C8750Q37119922-92C73275-4515-48D8-AC4E-E91D972B6F5DQ37381700-784C8489-A6BA-418D-8047-EF0A85C0B0DCQ37783631-6F5AC2D5-7992-4104-98D6-15580700AFEEQ37842342-FA93BC63-312B-42FA-9A4F-019B1C096DB0Q38009350-AB50E0EB-40A4-4339-A590-1A81F7BB9770Q38291355-562D03BD-103C-45F8-8E28-5F36A42AC0F2Q38767458-9C20BC21-B3D0-430F-B07A-DE4F755294E9Q39472050-1FE03F7E-5D47-4104-83AB-AC19DBC49BDBQ39667920-82076765-9B86-4265-A063-1CD2451A038EQ48224934-0AED480E-33E7-4B6D-995F-F04B2A2836E4Q54285466-C4132C6C-E9EE-4DFE-B6A4-2A6EE48A8C41Q55463347-FF30219D-78C1-40B8-912A-D7AA504901A7
P2860
Clinical implications of PRAME gene expression in childhood acute myeloid leukemia
description
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im März 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: March 2002)
@en
vedecký článok (publikovaný 2002-03)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd in 2002-03)
@nl
наукова стаття, опублікована в березні 2002
@uk
مقالة علمية (نشرت في مارس 2002)
@ar
name
Clinical implications of PRAME gene expression in childhood acute myeloid leukemia
@ast
Clinical implications of PRAME gene expression in childhood acute myeloid leukemia
@en
Clinical implications of PRAME gene expression in childhood acute myeloid leukemia
@nl
type
label
Clinical implications of PRAME gene expression in childhood acute myeloid leukemia
@ast
Clinical implications of PRAME gene expression in childhood acute myeloid leukemia
@en
Clinical implications of PRAME gene expression in childhood acute myeloid leukemia
@nl
prefLabel
Clinical implications of PRAME gene expression in childhood acute myeloid leukemia
@ast
Clinical implications of PRAME gene expression in childhood acute myeloid leukemia
@en
Clinical implications of PRAME gene expression in childhood acute myeloid leukemia
@nl
P2093
P3181
P1476
Clinical implications of PRAME gene expression in childhood acute myeloid leukemia
@en
P2093
Bernd Gruhn
Daniel Steinbach
Felix Zintl
Johann Hermann
Susanne Viehmann
P304
P3181
P356
10.1016/S0165-4608(01)00570-2
P407
P577
2002-03-01T00:00:00Z